Autism Clinical Trial
— BraininHandOfficial title:
Psychological and Quality of Life Impact of Brain in Hand
Verified date | June 2022 |
Source | Cornwall Partnership NHS Foundation Trust |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
A prospective cohort mixed study using both qualitative and quantitative elements. The quantitative component will involve tracking outcomes at baseline and at twelve weeks, using Health of the Nation Outcome Scale for People with a Learning Disability (for quality of life) and Hospital Anxiety and Depression Rating Scale (for anxiety and depression). The qualitative study will involve semi structured interviews with end users to understand usage and acceptability of Brain in Hand app with the added impact of the pandemic.
Status | Completed |
Enrollment | 101 |
Est. completion date | March 31, 2022 |
Est. primary completion date | December 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years to 80 Years |
Eligibility | Inclusion Criteria: 1. All who have been diagnosed with Autism Spectrum Disorder (ASD) as per DSM-5 criteria level (1) or post screening by health professional such as a GP and on the confirmatory diagnostic pathway. 2. Age ranges from 19 to 80. 3. Participant has been screened by the Columbia Suicide Rating Scale as not having risk concerns of suicide. 4. Access to smart devices with compatibility to running BiH. The Participant will require a Smart Phone and either a Laptop / Tablet / Note Book. 5. Has capacity to give informed consent and can give informed consent. 6. They can understand the BiH information. Exclusion Criteria: 1. Outside of stated age range within the inclusion criteria. 2. Any acute or chronic condition, particularly neurodevelopmental conditions such as significant intellectual disability, Level 2/3 DSM V ASD. 3. Diagnosed con-current psychological comorbidity (psychosis, severe depression etc.) that would limit the ability of the participant to take part in the study. 4. Anyone who declines to give consent or are unable to give informed consent. 5. Anyone who has been screened positive with the (C-SSRS) suicide risk scale. 6. Not willing to engage with smart device/internet. 7. Insufficient English language to understand and complete questionnaires. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Cornwall Partnership NHS Foundation Trust | Bodmin | Cornwall |
Lead Sponsor | Collaborator |
---|---|
Cornwall Partnership NHS Foundation Trust | braininhand.co.uk |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | What is the impact of BiH on quality of life over a three-month period? | The Health of the Nation Outcome Scales for People with Learning Disabilities is measured on a five-point scale (0-4) with 0 being no problem and 4 being very severe. It is completed at Baseline and 3 months and the scores will be compared | 3 months | |
Primary | What is the impact of BiH on the participant's mental health? | Hospital Anxiety and Depression Scale is measured on a four-point scale (0-3) with 0 being no problem and 4 being very severe. It is completed at Baseline and 3 months and the scores will be compared | 3 months | |
Primary | Level of acceptability (drop-out rates) | Drop out rates will be recorded | 3 months | |
Primary | Discover the participant's experience of using BiH App to measure outcomes of reliance on their care support | Short semi structured interviews with ten end users to understand usage and acceptability | 3 months | |
Primary | Understand how BiH impacts on coping skills | Short semi structured interviews with ten end users to understand usage and acceptability | 3 months | |
Primary | To gain understanding of how BIH has impacted on the autistic person's ability to manage challenging social situations | Short semi structured interviews with ten end users to understand usage and acceptability | 3 months | |
Primary | Does BiH App help autistic people feel safe? | Short semi structured interviews with ten end users to understand usage and acceptability | 3 months | |
Primary | Does the BiH help autistic people feel more independent? | Short semi structured interviews with ten end users to understand usage and acceptability | 3 months | |
Primary | Can access 24/7 telephone support help autistic people feel self-empowered to manage their anxiety? | Short semi structured interviews with ten end users to understand usage and acceptability | 3 months | |
Primary | To gain an understanding of how BiH Traffic Light system helps a person manage their anxiety, independence and support their coping skills | Short semi structured interviews with ten end users to understand usage and acceptability | 3 months | |
Primary | Does the participant believe remote support has improved their access to healthcare during the pandemic? | Short semi structured interviews with ten end users to understand usage and acceptability | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05302167 -
Molehill Mountain Feasibility Study.
|
N/A | |
Completed |
NCT04167839 -
Effects of Sensory Diets on Children's Sensory Processing Skills, Psychosocial Skills, and Classroom Engagement
|
N/A | |
Terminated |
NCT04049981 -
Investigation of Mechanisms of Action in Superpower Glass
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT06080087 -
Implementation Toolkit to Enhance EBP Among Marginalized Families
|
N/A | |
Recruiting |
NCT04107064 -
Achieving Steady Work Among Adults With Autism Through Specialized Employment Program
|
N/A | |
Completed |
NCT03206996 -
Exposure Therapy for Auditory Sensitivity in Autism
|
N/A | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Completed |
NCT05588570 -
Coaching Children With Anxiety and Autism Through Telehealth
|
N/A | |
Enrolling by invitation |
NCT06058104 -
Evaluating Efficacy of a Digital Game Therapeutic for Children With Autism
|
N/A | |
Withdrawn |
NCT02414451 -
Trial of Propranolol in Adults and Adolescents With ASD and Predictors of Response
|
N/A | |
Completed |
NCT02847182 -
Cord Blood Infusion for Children With Autism Spectrum Disorder
|
Phase 2 | |
Completed |
NCT03002363 -
The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance
|
Phase 1 | |
Completed |
NCT02911194 -
a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT02508922 -
Trial of Vitamin D3 Supplementation in Paediatric Autism
|
N/A | |
Completed |
NCT02720900 -
Prebiotic Intervention for Autism Spectrum Disorders
|
N/A | |
Completed |
NCT02536365 -
Sensory Integration Therapy in Autism: Mechanisms and Effectiveness
|
N/A | |
Completed |
NCT02708290 -
Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
|
||
Recruiting |
NCT01836562 -
A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism
|
Phase 1/Phase 2 | |
Recruiting |
NCT02255565 -
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
|
Phase 4 | |
Completed |
NCT02154828 -
Clinical Evaluation of Integrative Practices Units Infant and Child Care for Unit Children With Typical or Atypical Autism (AUTISM)
|